California State Teachers Retirement System (CalSTRS)’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
31,914
-292
-0.9% -$8.09K ﹤0.01% 1739
2025
Q4
$496K Buy
32,206
+11,870
+58% +$236K ﹤0.01% 2099
2025
Q3
$416K Buy
20,336
+6
+0% +$121 ﹤0.01% 2151
2025
Q2
$408K Sell
20,330
-584
-3% -$11.1K ﹤0.01% 2128
2025
Q1
$412K Hold
20,914
﹤0.01% 2125
2024
Q4
$471K Buy
20,914
+1,940
+10% +$50.3K ﹤0.01% 2142
2024
Q3
$485K Sell
18,974
-547
-3% -$12.7K ﹤0.01% 2138
2024
Q2
$456K Buy
19,521
+380
+2% +$8K ﹤0.01% 2128
2024
Q1
$337K Sell
19,141
-1,189
-6% -$18.2K ﹤0.01% 2323
2023
Q4
$281K Sell
20,330
-1,179
-5% -$14.4K ﹤0.01% 2401
2023
Q3
$294K Sell
21,509
-6,097
-22% -$103K ﹤0.01% 2422
2023
Q2
$563K Buy
+27,606
New +$558K ﹤0.01% 2236
2021
Q2
Sell
-2,895
Closed -$98K 3133
2021
Q1
$98K Hold
2,895
﹤0.01% 3044
2020
Q4
$255K Buy
2,895
+1,031
+55% +$86.5K ﹤0.01% 2737
2020
Q3
$152K Hold
1,864
﹤0.01% 2849
2020
Q2
$206K Buy
+1,864
New +$209K ﹤0.01% 2701

Other funds holding ELVN

California State Teachers Retirement System (CalSTRS)'s ELVN Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Enliven Therapeutics (ELVN) stake by 0.91% in Q1 2026, selling an estimated $8.09K and leaving 31,914 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

California State Teachers Retirement System (CalSTRS) first reported a position in ELVN in Q2 2020 and has held it in 16 quarters since. 170 funds tracked by Wall St. Rank hold ELVN as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 31,914 shares of Enliven Therapeutics worth $1.25M as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 292 Enliven Therapeutics shares in Q1 2026, an estimated $8.09K.
  • Enliven Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #1739 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Enliven Therapeutics in Q2 2020 and has held it in 16 quarters since.
  • 170 funds tracked by Wall St. Rank held Enliven Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.